Neurosearch A/S Inks Development Deal with Eli Lilly and Company (JOBS)

February 17, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

COPENHAGEN, Feb 17 (Reuters) - NeuroSearch on Tuesday announced a three-year drug discovery and development deal with Eli Lilly and Co, sending the Danish biotech company's shares as much as 11 percent higher.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Europe

Eli Lilly and Company